Spyre Therapeutics, Inc. (SYRE)

Last Closing Price: 33.24 (2026-01-16)

Expense Ratio (Annual)

Expense Ratio: A measure of profitability used by an insurance company to indicate how well it is performing in its daily operations. The expense ratio is calculated by taking the operating expenses and then dividing them by earned premium. Calculated as: (Total Operating Expenses - Underwriting Losses Total) / Net Premiums Earned

Spyre Therapeutics, Inc. (SYRE) Expense Ratio data is not available.

Figures for fiscal year ending 2024-12-31
Income Statement Financials
--
$-208.02M
--
--
$208.57M
$-208.57M
$0.60M
$-207.97M
$-207.97M
$-208.02M
$-208.02M
$-208.02M
$-208.02M
$-208.57M
$-219.97M
47.03M
47.03M
$-4.42
$-4.42
Balance Sheet Financials
$608.47M
--
$0.01M
$608.48M
$54.06M
--
$36.62M
$90.68M
$361.98M
$517.80M
$517.80M
60.26M
Cash Flow Statement Financials
$-157.41M
$-353.29M
$410.91M
$189.22M
$89.42M
$-99.79M
$44.83M
--
--
Fundamental Metrics & Ratios
11.26
--
--
--
--
--
--
--
--
--
--
$-157.41M
--
Expense Ratio
--
--
--
--
--
--
-57.47%
-40.17%
-34.19%
-40.17%
$8.59
$-3.35
$-3.35